Work

Novel Targeted Therapies for Renal Cell Carcinoma

Year: 2023

Type: review

Source: Hematology/Oncology Clinics of North America

DOI: 10.1016/j.hoc.2023.05.022

Authors: Renée Maria Saliby, Eddy Saad, Chris Labaki, Wenxin Xu, David A. Braun, Srinivas R. Viswanathan, Ziad Bakouny

Institutions: Yale Cancer Center, Yale University, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Harvard University, Dana-Farber/Harvard Cancer Center, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Doris Duke Charitable Foundation, V Foundation for Cancer Research, Kidney Cancer Association, Rally Foundation, Yale Cancer Center, National Institutes of Health, National Cancer Institute, DOD Peer Reviewed Cancer Research Program

Awards: G4136751113, G4751381667, G7271780369, Cancer Center Support Grant

OpenAlex ID: W4382405027

FWCI: 0.139

Cites: 60

Cited by: 3

Related to: 10